La thérapie familiale en francophonie (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.

Identifieur interne : 001708 ( Main/Exploration ); précédent : 001707; suivant : 001709

Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.

Auteurs : R. Weber [Suisse] ; B. Ledergerber [Suisse] ; M. Opravil [Suisse] ; W. Siegenthaler [Suisse] ; R. Lüthy [Suisse]

Source :

RBID : ISTEX:7324C6C446021B7115521B2108CB125E57A13C31

Abstract

OBJECTIVE--To see whether misusers of injected drugs who stop injecting or switch to a programme of maintenance treatment with methadone have a reduced risk of progression of HIV infection when compared with a group of persistent misusers. DESIGN--Observational cohort study in HIV seropositive subjects with a current or past history of misusing injected drugs. SETTING--HIV outpatient clinic at the University Hospital of Zurich, Switzerland. PATIENTS--297 Current and former parenteral drug misusers (median age 27) with asymptomatic HIV infection. During the observation period 80 subjects adhered to a programme of maintenance treatment with methadone, 124 continued with parenteral drug misuse, and 93 former misusers remained free of illicit drugs. No antiretroviral treatment was given during the study. MAIN OUTCOME MEASURES--Probability of progression of HIV infection from asymptomatic to symptomatic (Centers for Disease Control stage IV) as calculated by life table analysis and compared in the three groups of patients by means of a log rank test, and predictors of disease progression as analysed with a Cox proportional hazards regression model. RESULTS--The 297 patients were followed up for a median of 16 months. The median duration of injecting drug misuse before enrollment was 7.1 years. There were no significant differences among the three groups with respect to CD4+ counts at the beginning of the study (median 0.44 x 10(9)/l). Life table analysis showed a significantly lower probability of progression of HIV disease in both the methadone treated group and former drug misusers than in persistent injecting drug misusers. Multivariate regression analysis showed a relative risk of progression of the disease of 1.78 (95% confidence interval 1.20 to 2.67; p less than 0.01) in persistent injecting drug misusers, 0.48 (0.29 to 0.77; p less than 0.01) in the methadone treated group, and 0.66 (0.41 to 1.06; p = 0.085) in former drug misusers. CONCLUSIONS--Stopping the misuse of injected drugs slows the progression of HIV disease in infected subjects. Drug treatment programmes are effective in secondary prevention of HIV associated morbidity.

Url:
DOI: 10.1136/bmj.301.6765.1362


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.</title>
<author>
<name sortKey="Weber, R" sort="Weber, R" uniqKey="Weber R" first="R" last="Weber">R. Weber</name>
</author>
<author>
<name sortKey="Ledergerber, B" sort="Ledergerber, B" uniqKey="Ledergerber B" first="B" last="Ledergerber">B. Ledergerber</name>
</author>
<author>
<name sortKey="Opravil, M" sort="Opravil, M" uniqKey="Opravil M" first="M" last="Opravil">M. Opravil</name>
</author>
<author>
<name sortKey="Siegenthaler, W" sort="Siegenthaler, W" uniqKey="Siegenthaler W" first="W" last="Siegenthaler">W. Siegenthaler</name>
</author>
<author>
<name sortKey="Luthy, R" sort="Luthy, R" uniqKey="Luthy R" first="R" last="Lüthy">R. Lüthy</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:7324C6C446021B7115521B2108CB125E57A13C31</idno>
<date when="1990" year="1990">1990</date>
<idno type="doi">10.1136/bmj.301.6765.1362</idno>
<idno type="url">https://api.istex.fr/document/7324C6C446021B7115521B2108CB125E57A13C31/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001998</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001998</idno>
<idno type="wicri:Area/Istex/Curation">001994</idno>
<idno type="wicri:Area/Istex/Checkpoint">001269</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001269</idno>
<idno type="wicri:doubleKey">0959-8138:1990:Weber R:progression:of:hiv</idno>
<idno type="wicri:Area/Main/Merge">001735</idno>
<idno type="wicri:Area/Main/Curation">001708</idno>
<idno type="wicri:Area/Main/Exploration">001708</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.</title>
<author>
<name sortKey="Weber, R" sort="Weber, R" uniqKey="Weber R" first="R" last="Weber">R. Weber</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Medicine, University Hospital, Zürich</wicri:regionArea>
<placeName>
<settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ledergerber, B" sort="Ledergerber, B" uniqKey="Ledergerber B" first="B" last="Ledergerber">B. Ledergerber</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Medicine, University Hospital, Zürich</wicri:regionArea>
<placeName>
<settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Opravil, M" sort="Opravil, M" uniqKey="Opravil M" first="M" last="Opravil">M. Opravil</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Medicine, University Hospital, Zürich</wicri:regionArea>
<placeName>
<settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Siegenthaler, W" sort="Siegenthaler, W" uniqKey="Siegenthaler W" first="W" last="Siegenthaler">W. Siegenthaler</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Medicine, University Hospital, Zürich</wicri:regionArea>
<placeName>
<settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Luthy, R" sort="Luthy, R" uniqKey="Luthy R" first="R" last="Lüthy">R. Lüthy</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Medicine, University Hospital, Zürich</wicri:regionArea>
<placeName>
<settlement type="city">Zurich</settlement>
<region nuts="3" type="region">Canton de Zurich</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">British Medical Journal</title>
<title level="j" type="abbrev">BMJ</title>
<idno type="ISSN">0959-8138</idno>
<idno type="eISSN">1468-5833</idno>
<imprint>
<publisher>British Medical Journal Publishing Group</publisher>
<date type="published" when="1990-12-15">1990-12-15</date>
<biblScope unit="volume">301</biblScope>
<biblScope unit="issue">6765</biblScope>
<biblScope unit="page" from="1362">1362</biblScope>
</imprint>
<idno type="ISSN">0959-8138</idno>
</series>
<idno type="istex">7324C6C446021B7115521B2108CB125E57A13C31</idno>
<idno type="DOI">10.1136/bmj.301.6765.1362</idno>
<idno type="href">bmj-301-1362.pdf</idno>
<idno type="PMID">1980219</idno>
<idno type="local">bmj;301/6765/1362</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0959-8138</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">OBJECTIVE--To see whether misusers of injected drugs who stop injecting or switch to a programme of maintenance treatment with methadone have a reduced risk of progression of HIV infection when compared with a group of persistent misusers. DESIGN--Observational cohort study in HIV seropositive subjects with a current or past history of misusing injected drugs. SETTING--HIV outpatient clinic at the University Hospital of Zurich, Switzerland. PATIENTS--297 Current and former parenteral drug misusers (median age 27) with asymptomatic HIV infection. During the observation period 80 subjects adhered to a programme of maintenance treatment with methadone, 124 continued with parenteral drug misuse, and 93 former misusers remained free of illicit drugs. No antiretroviral treatment was given during the study. MAIN OUTCOME MEASURES--Probability of progression of HIV infection from asymptomatic to symptomatic (Centers for Disease Control stage IV) as calculated by life table analysis and compared in the three groups of patients by means of a log rank test, and predictors of disease progression as analysed with a Cox proportional hazards regression model. RESULTS--The 297 patients were followed up for a median of 16 months. The median duration of injecting drug misuse before enrollment was 7.1 years. There were no significant differences among the three groups with respect to CD4+ counts at the beginning of the study (median 0.44 x 10(9)/l). Life table analysis showed a significantly lower probability of progression of HIV disease in both the methadone treated group and former drug misusers than in persistent injecting drug misusers. Multivariate regression analysis showed a relative risk of progression of the disease of 1.78 (95% confidence interval 1.20 to 2.67; p less than 0.01) in persistent injecting drug misusers, 0.48 (0.29 to 0.77; p less than 0.01) in the methadone treated group, and 0.66 (0.41 to 1.06; p = 0.085) in former drug misusers. CONCLUSIONS--Stopping the misuse of injected drugs slows the progression of HIV disease in infected subjects. Drug treatment programmes are effective in secondary prevention of HIV associated morbidity.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Suisse</li>
</country>
<region>
<li>Canton de Zurich</li>
</region>
<settlement>
<li>Zurich</li>
</settlement>
</list>
<tree>
<country name="Suisse">
<region name="Canton de Zurich">
<name sortKey="Weber, R" sort="Weber, R" uniqKey="Weber R" first="R" last="Weber">R. Weber</name>
</region>
<name sortKey="Ledergerber, B" sort="Ledergerber, B" uniqKey="Ledergerber B" first="B" last="Ledergerber">B. Ledergerber</name>
<name sortKey="Luthy, R" sort="Luthy, R" uniqKey="Luthy R" first="R" last="Lüthy">R. Lüthy</name>
<name sortKey="Opravil, M" sort="Opravil, M" uniqKey="Opravil M" first="M" last="Opravil">M. Opravil</name>
<name sortKey="Siegenthaler, W" sort="Siegenthaler, W" uniqKey="Siegenthaler W" first="W" last="Siegenthaler">W. Siegenthaler</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/TherFamFrancoV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001708 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001708 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Psychologie
   |area=    TherFamFrancoV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:7324C6C446021B7115521B2108CB125E57A13C31
   |texte=   Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone.
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Tue May 16 11:23:40 2017. Site generation: Mon Feb 12 23:51:41 2024